Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Omron to Distribute NeuroMetrix’s Diabetic Neuropathy Test Device in China

publication date: Dec 11, 2013
Omron Medical Devices obtained China distribution rights to a diabetic peripheral neuropathy (DPN) test device developed by NeuroMetrix of Philadelphia. The NC-stat® DPNCheck® test is a point-of-care diagnostic for early detection of DPN, a complication in about half the diabetic population. The licensing is in addition to an earlier partnership between the two companies that gave Omron rights to the device in Japan, where Omron is headquartered. More details....

Stock Symbol: (NSDQ: NURO)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital